Lu-177-PSMA PNT2002

PNT2002 · POINT Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lu-177-PSMA PNT2002, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment [Phase 3]

See pricing